Bioprinting Markets Opportunity Analysis and 10 Year Forecast April 2017 | Page 4

Bioprinting Markets: Materials, Equipment and Applications – 2017 to 2027: An Opportunity Analysis and Ten-Year Forecast The report explores the commercial implications of bioprinting in depth and includes: An assessment of the product/market strategies of emerging and established firms in the bioprinting space. While many of the firms pioneering this space are well-funded and innovative start-ups, bioprinting is also attracting the attention of some of the largest multinationals in big pharma and cosmetics, for example. Astellas Pharma, Bristol-Meyers Squibb, Merck, Novartis, Procter and Gamble, Roche and others all have bioprinting programs, as do some of the large research facilities in the world, such as the National Institutes of Health in the US. Meanwhile, bioprinting continues to be a favorite target of venture capital firms. A full discussion of the latest developments in droplet and extrusion bio printer and what they mean both technically and from a business perspective. Also included is an analysis of the very diverse market for bioprinted materials. Emerging bioinks, include combinations of polymers, ceramics, cells, cell aggregates, peptides, growth factors, hydrogels, scaffold components, and other materials. Check for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=954218 Order this report by calling [phone] or Send an email to [email protected] with your contact details and questions if any. © ReportsnReports.com / Contact [email protected] 4